Rights and permissions
About this article
Cite this article
Bevacizumab doesn't add up for NSCLC. Pharmacoecon. Outcomes News 638, 7 (2011). https://doi.org/10.2165/00151234-201106380-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106380-00019